NZ Herald
  • Home
  • Latest news
  • Video
  • New Zealand
  • Sport
  • World
  • Business
  • Entertainment
  • Podcasts
  • Quizzes
  • Opinion
  • Lifestyle
  • Travel
  • Viva
  • Weather forecasts

Subscriptions

  • Herald Premium
  • Viva Premium
  • The Listener
  • BusinessDesk

Sections

  • Latest news
  • New Zealand
    • All New Zealand
    • Crime
    • Politics
    • Education
    • Open Justice
    • Scam Update
  • Budget 2025
  • On The Up
  • World
    • All World
    • Australia
    • Asia
    • UK
    • United States
    • Middle East
    • Europe
    • Pacific
  • Business
    • All Business
    • MarketsSharesCurrencyCommoditiesStock TakesCrypto
    • Markets with Madison
    • Media Insider
    • Business analysis
    • Personal financeKiwiSaverInterest ratesTaxInvestment
    • EconomyInflationGDPOfficial cash rateEmployment
    • Small business
    • Business reportsMood of the BoardroomProject AucklandSustainable business and financeCapital markets reportAgribusiness reportInfrastructure reportDynamic business
    • Deloitte Top 200 Awards
    • CompaniesAged CareAgribusinessAirlinesBanking and financeConstructionEnergyFreight and logisticsHealthcareManufacturingMedia and MarketingRetailTelecommunicationsTourism
  • Opinion
    • All Opinion
    • Analysis
    • Editorials
    • Business analysis
    • Premium opinion
    • Letters to the editor
  • Sport
    • All Sport
    • OlympicsParalympics
    • RugbySuper RugbyNPCAll BlacksBlack FernsRugby sevensSchool rugby
    • CricketBlack CapsWhite Ferns
    • Racing
    • NetballSilver Ferns
    • LeagueWarriorsNRL
    • FootballWellington PhoenixAuckland FCAll WhitesFootball FernsEnglish Premier League
    • GolfNZ Open
    • MotorsportFormula 1
    • Boxing
    • UFC
    • BasketballNBABreakersTall BlacksTall Ferns
    • Tennis
    • Cycling
    • Athletics
    • SailingAmerica's CupSailGP
    • Rowing
  • Lifestyle
    • All Lifestyle
    • Viva - Food, fashion & beauty
    • Society Insider
    • Royals
    • Sex & relationships
    • Food & drinkRecipesRecipe collectionsRestaurant reviewsRestaurant bookings
    • Health & wellbeing
    • Fashion & beauty
    • Pets & animals
    • The Selection - Shop the trendsShop fashionShop beautyShop entertainmentShop giftsShop home & living
    • Milford's Investing Place
  • Entertainment
    • All Entertainment
    • TV
    • MoviesMovie reviews
    • MusicMusic reviews
    • BooksBook reviews
    • Culture
    • ReviewsBook reviewsMovie reviewsMusic reviewsRestaurant reviews
  • Travel
    • All Travel
    • News
    • New ZealandNorthlandAucklandWellingtonCanterburyOtago / QueenstownNelson-TasmanBest NZ beaches
    • International travelAustraliaPacific IslandsEuropeUKUSAAfricaAsia
    • Rail holidays
    • Cruise holidays
    • Ski holidays
    • Luxury travel
    • Adventure travel
  • Kāhu Māori news
  • Environment
    • All Environment
    • Our Green Future
  • Talanoa Pacific news
  • Property
    • All Property
    • Property Insider
    • Interest rates tracker
    • Residential property listings
    • Commercial property listings
  • Health
  • Technology
    • All Technology
    • AI
    • Social media
  • Rural
    • All Rural
    • Dairy farming
    • Sheep & beef farming
    • Horticulture
    • Animal health
    • Rural business
    • Rural life
    • Rural technology
    • Opinion
    • Audio & podcasts
  • Weather forecasts
    • All Weather forecasts
    • Kaitaia
    • Whangārei
    • Dargaville
    • Auckland
    • Thames
    • Tauranga
    • Hamilton
    • Whakatāne
    • Rotorua
    • Tokoroa
    • Te Kuiti
    • Taumaranui
    • Taupō
    • Gisborne
    • New Plymouth
    • Napier
    • Hastings
    • Dannevirke
    • Whanganui
    • Palmerston North
    • Levin
    • Paraparaumu
    • Masterton
    • Wellington
    • Motueka
    • Nelson
    • Blenheim
    • Westport
    • Reefton
    • Kaikōura
    • Greymouth
    • Hokitika
    • Christchurch
    • Ashburton
    • Timaru
    • Wānaka
    • Oamaru
    • Queenstown
    • Dunedin
    • Gore
    • Invercargill
  • Meet the journalists
  • Promotions & competitions
  • OneRoof property listings
  • Driven car news

Puzzles & Quizzes

  • Puzzles
    • All Puzzles
    • Sudoku
    • Code Cracker
    • Crosswords
    • Cryptic crossword
    • Wordsearch
  • Quizzes
    • All Quizzes
    • Morning quiz
    • Afternoon quiz
    • Sports quiz

Regions

  • Northland
    • All Northland
    • Far North
    • Kaitaia
    • Kerikeri
    • Kaikohe
    • Bay of Islands
    • Whangarei
    • Dargaville
    • Kaipara
    • Mangawhai
  • Auckland
  • Waikato
    • All Waikato
    • Hamilton
    • Coromandel & Hauraki
    • Matamata & Piako
    • Cambridge
    • Te Awamutu
    • Tokoroa & South Waikato
    • Taupō & Tūrangi
  • Bay of Plenty
    • All Bay of Plenty
    • Katikati
    • Tauranga
    • Mount Maunganui
    • Pāpāmoa
    • Te Puke
    • Whakatāne
  • Rotorua
  • Hawke's Bay
    • All Hawke's Bay
    • Napier
    • Hastings
    • Havelock North
    • Central Hawke's Bay
    • Wairoa
  • Taranaki
    • All Taranaki
    • Stratford
    • New Plymouth
    • Hāwera
  • Manawatū - Whanganui
    • All Manawatū - Whanganui
    • Whanganui
    • Palmerston North
    • Manawatū
    • Tararua
    • Horowhenua
  • Wellington
    • All Wellington
    • Kapiti
    • Wairarapa
    • Upper Hutt
    • Lower Hutt
  • Nelson & Tasman
    • All Nelson & Tasman
    • Motueka
    • Nelson
    • Tasman
  • Marlborough
  • West Coast
  • Canterbury
    • All Canterbury
    • Kaikōura
    • Christchurch
    • Ashburton
    • Timaru
  • Otago
    • All Otago
    • Oamaru
    • Dunedin
    • Balclutha
    • Alexandra
    • Queenstown
    • Wanaka
  • Southland
    • All Southland
    • Invercargill
    • Gore
    • Stewart Island
  • Gisborne

Media

  • Video
    • All Video
    • NZ news video
    • Business news video
    • Politics news video
    • Sport video
    • World news video
    • Lifestyle video
    • Entertainment video
    • Travel video
    • Markets with Madison
    • Kea Kids news
  • Podcasts
    • All Podcasts
    • The Front Page
    • On the Tiles
    • Ask me Anything
    • The Little Things
    • Cooking the Books
  • Cartoons
  • Photo galleries
  • Today's Paper - E-editions
  • Photo sales
  • Classifieds

NZME Network

  • Advertise with NZME
  • OneRoof
  • Driven Car Guide
  • BusinessDesk
  • Newstalk ZB
  • What the Actual
  • Sunlive
  • ZM
  • The Hits
  • Coast
  • Radio Hauraki
  • The Alternative Commentary Collective
  • Gold
  • Flava
  • iHeart Radio
  • Hokonui
  • Radio Wanaka
  • iHeartCountry New Zealand
  • Restaurant Hub
  • NZME Events

SubscribeSign In
Advertisement
Advertise with NZME.
Home / Lifestyle

'Disease mongering' has created a multibillion-dollar industry - critics

Washington Post
26 Mar, 2015 01:45 AM5 mins to read

Subscribe to listen

Access to Herald Premium articles require a Premium subscription. Subscribe now to listen.
Already a subscriber?  Sign in here

Listening to articles is free for open-access content—explore other articles or learn more about text-to-speech.
‌
Save

    Share this article

Disease mongering plays a big role in the "anti-aging" marketing for human growth hormone. Photo / 123RF

Disease mongering plays a big role in the "anti-aging" marketing for human growth hormone. Photo / 123RF

Are you tired? Do you have low energy? Have you put on some weight recently?

Despite the advances of modern medicine, there is no magic pill or fountain of youth to combat aging, poor food choices or bad exercise habits.

But if you've been watching infomercials or flipping through a magazine lately, you may think testosterone could be a cure-all. The "low T" movement, also known as "andropause," targets aging men for their declining testosterone levels. And over the past decade, it's become a multibillion-dollar industry.

A new editorial, released Tuesday in the Journal of the American Geriatrics Society, makes the case that "disease mongering" created a surge in the prescribing and the use of testosterone and human growth hormone in the United States.

So what exactly is "disease mongering?" It's the concept of selling sickness to otherwise healthy people. Many people have normal ailments that are simply a part of life. Not every symptom means that something is seriously wrong or even wrong at all. But if you can expand and broaden the idea of what diseases exist - or "medicalise" what may be normal signs of ageing - then you can also expand the opportunities for treatments. And that, coupled with aggressive promotion, can create a lucrative industry. That's disease mongering in a nutshell.

Advertisement
Advertise with NZME.
Advertisement
Advertise with NZME.

Thomas Perls, co-author of the editorial, practices geriatric medicine at Boston Medical Center and has become a well-known critic of the burgeoning anti-aging industry. He believes the baby boomer generation has become particularly vulnerable to disease mongering, mostly because of savvy marketing campaigns.

"They're a well-educated, wealthier group of people who, on a regular basis, are exposed to new cures saying, 'We can stop or reverse your aging,' or 'We can make this go away,' or 'We can make your sex life better,' " Perls said in a phone interview.

"They may take it hook, line and sinker, especially if it's someone in a white coat with a stethoscope around their neck."

Advertisement
Advertise with NZME.

The "disease mongering" claim doesn't sit well with those on the other side of the spectrum, who claim that testosterone has valid and proven uses.

"The allegation of 'disease mongering' is highly disturbing," said Abraham Morgentaler, a practicing urologist, associate clinical professor of urology at Harvard Medical School and author of the book, Testosterone For Life.

"This type of allegation is nearly always made by individuals with no experience treating patients with the condition, and so they have never seen men suffering from testosterone deficiency, nor observed the satisfying response with treatment. This is a real condition experienced by real men."

In the editorial, Perls and his co-author, David Handelsman, a professor of endocrinology at the ANZAC Research Institute at the University of Sydney in Australia, write that disease mongering also plays a big role in the "anti-aging" marketing for human growth hormone. The use of HGH is only medically valid for three conditions, all of which are rare.

Discover more

Lifestyle

Curvy women produce smarter children, scientists claim

19 Jan 02:25 AM
Lifestyle

Starting to thin out? Hair loss doesn't have to lead to baldness

21 Jan 11:00 PM
Lifestyle

Dear D&P: My husband won't let me talk to his best friend's wife

20 Feb 07:30 PM

"The disease mongering is a misinformation campaign," Perls said.

The editorial cites a 10-fold increase in testosterone prescriptions in the United States in the past decade. Pharmaceutical sales of testosterone increased from $324 million in 2002 to $2 billion in 2012.

That growth hasn't gone unnoticed. Time Magazine featured a Manopause cover last summer, with the subtitle "Aging, Insecurity and the $2 billion industry".

Critics have raised concerns about safety issues, misleading advertising and lax guidelines for prescribing testosterone. Earlier this month, the FDA cautioned that many men are using testosterone for "no apparent reason other than aging," and that the "benefits and safety" of such use have not been determined. The FDA required manufacturers of testosterone products to change labels to disclose the approved uses for testosterone and to reflect the possible risks of heart attacks and strokes. The agency also required manufacturers to carry out a well-designed clinical trial to examine the safety risks.

Testosterone, a male hormone and anabolic steroid, is used to treat men diagnosed with hypogonadism, a condition where the body cannot produce enough testosterone because of problems with the testicles, pituitary gland or the hypothalamus. When the FDA convened a committee to discuss testosterone last fall, much of the dialogue focused on the increasing trend of giving testosterone for aging and, in some cases, without even testing testosterone levels before beginning the treatment.

Mark E. Richards, a North Bethesda, plastic surgeon who treats hundreds of patients with hormone therapy, testified at the FDA committee meeting in September. Richards, who uses "bio-identical testosterone pellet therapy" in his practice, said he was disappointed that many of the committee members seemed unaware of existing medical literature on testosterone.

Advertisement
Advertise with NZME.

When it comes to the "disease mongering" argument that Perls takes, Richards said he can't entirely disagree with that position.

"He's half-right in that the pharmaceutical industry has hyped it beyond the scientific reality of the situation," Richards said.

"He's wrong in that there is a legitimate medical problem that occurs with low testosterone."

Bruce Campbell, chairman of the executive health department at Lahey Hospital & Medical Center said some of his patients have asked for their testosterone levels to be checked after they saw an ad or heard that a friend had taken testosterone. Campbell said he takes a conservative approach to testosterone use and proposes lifestyle modifications, like weight loss or exercise regimens, before prescribing the hormone.

"Certainly there has been some inappropriate advertising and marketing," said Campbell, an internal medicine physician. "Some of the ads out of there might be well-intentioned, but they do tend to target a man's masculinity."

Save

    Share this article

Latest from Lifestyle

Premium
Lifestyle

Society Insider: Did Pitt stay at Mowbray's mansion? Peter Huljich's new life; why hairstylist to the rich list is moving on

21 May 05:00 PM
Premium
Opinion

Opinion: Will Auckland's food snobs ever be satisfied?

21 May 06:00 AM
Premium
Lifestyle

Winter citrus fruits: Do they really help boost immunity?

21 May 06:00 AM

Sponsored: How much is too much?

sponsored
Advertisement
Advertise with NZME.

Latest from Lifestyle

Premium
Society Insider: Did Pitt stay at Mowbray's mansion? Peter Huljich's new life; why hairstylist to the rich list is moving on

Society Insider: Did Pitt stay at Mowbray's mansion? Peter Huljich's new life; why hairstylist to the rich list is moving on

21 May 05:00 PM

Plus, chef Polly Markus announces her next life-changing project.

Premium
Opinion: Will Auckland's food snobs ever be satisfied?

Opinion: Will Auckland's food snobs ever be satisfied?

21 May 06:00 AM
Premium
Winter citrus fruits: Do they really help boost immunity?

Winter citrus fruits: Do they really help boost immunity?

21 May 06:00 AM
Tami Neilson joins Tauranga Arts Festival lineup with new tour

Tami Neilson joins Tauranga Arts Festival lineup with new tour

21 May 03:00 AM
Sponsored: Cosy up to colour all year
sponsored

Sponsored: Cosy up to colour all year

NZ Herald
  • About NZ Herald
  • Meet the journalists
  • Newsletters
  • Classifieds
  • Help & support
  • Contact us
  • House rules
  • Privacy Policy
  • Terms of use
  • Competition terms & conditions
  • Our use of AI
Subscriber Services
  • NZ Herald e-editions
  • Daily puzzles & quizzes
  • Manage your digital subscription
  • Manage your print subscription
  • Subscribe to the NZ Herald newspaper
  • Subscribe to Herald Premium
  • Gift a subscription
  • Subscriber FAQs
  • Subscription terms & conditions
  • Promotions and subscriber benefits
NZME Network
  • The New Zealand Herald
  • The Northland Age
  • The Northern Advocate
  • Waikato Herald
  • Bay of Plenty Times
  • Rotorua Daily Post
  • Hawke's Bay Today
  • Whanganui Chronicle
  • Viva
  • NZ Listener
  • What the Actual
  • Newstalk ZB
  • BusinessDesk
  • OneRoof
  • Driven CarGuide
  • iHeart Radio
  • Restaurant Hub
NZME
  • About NZME
  • NZME careers
  • Advertise with NZME
  • Digital self-service advertising
  • Book your classified ad
  • Photo sales
  • NZME Events
  • © Copyright 2025 NZME Publishing Limited
TOP